Lentiviral vector gene therapy for beta-thalassemia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lentiviral vector gene therapy for beta-thalassemia, covering 2025-08-05 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients [NA]